Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: Post-hoc analysis of the randomized PRASFIT-ACS study-Reference-Cited by-同舟云学术

Optimal cutoff value of P2Y12 reaction units to prevent major adverse cardiovascular events in the acute periprocedural period: Post-hoc analysis of the randomized PRASFIT-ACS study

Published:2015-03 Issue: Volume:182 Page:541-548
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Nakamura Masato,Isshiki Takaaki,Kimura Takeshi,Ogawa Hisao,Yokoi Hiroyoshi,Nanto Shinsuke,Takayama Morimasa,Kitagawa Kazuo,Ikeda Yasuo,Saito Shigeru

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. TCT-724 Clopidogrel Loading doses result in Favourable Changes in Nitric Oxide (NO) Metabolism in Patients with Stable Angina Undergoing Percutaneous Coronary Intervention (PCI)

2. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

3. New P2Y12 inhibitors;Cattaneo;Circulation,2010

4. Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel;Brandt;J. Thromb. Haemost.,2007

5. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects;Hulot;Blood,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Stewardship: Evaluation of Platelet Reactivity-Guided Cangrelor Dosing Using the VerifyNow® Assay;Journal of Cardiovascular Pharmacology;2024-02-08

2. An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial;Circulation;2023-11-23

3. Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study;Cardiovascular Drugs and Therapy;2023-04-25

4. High platelet reactivity is a predictor of left ventricular remodelling in patients with acute myocardial infarction;ESC Heart Failure;2022-07-31

5. Antiplatelet Therapy and Periprocedural Risk Factor Analysis for Pipeline Embolization Device Treatment of Unruptured Internal Carotid Artery Aneurysms: A Retrospective, Multicenter Analysis;World Neurosurgery;2022-01